Food (Health) Supplement Retailers — NAICS 456191 (United States)

A Histometrics industry primer for public- and private-market investors.

---

1. Overview

This is the business of selling vitamins, minerals, protein powders, herbal products, and other dietary supplements out of dedicated specialty stores and their websites, think GNC (formerly General Nutrition Centers) and The Vitamin Shoppe, plus thousands of independent "vitamin shops" and health-food supplement counters. It is a retail channel, not a manufacturer: these stores buy branded and private-label product and resell it to walk-in and online consumers.

Americans are heavy, habitual supplement buyers. Roughly three-quarters of U.S. adults take a dietary supplement, and users spend a median of about $50 a month on them.[6] Demand is structural (an aging population, preventive-health culture, sports nutrition, the GLP-1 weight-loss wave) and recurring (people re-buy the same bottle monthly). The catch, and the whole investment story here, is that the specialty-store channel covered by this NAICS (North American Industry Classification System) code has been losing share for a decade to mass merchants, warehouse clubs, drugstores, and online marketplaces.

Public vs. private ways in: there is essentially no pure-play U.S.-listed supplement retailer today. The two iconic national chains are both privately held, GNC is owned by a Chinese pharmaceutical group, and The Vitamin Shoppe was bought by private-equity firms in 2025.[20][21][25][26] Public-market investors reach the theme indirectly, through supplement brand makers, diversified grocers, and the mass/online retailers that actually move most of the volume. Private-market investors get the more direct exposure, through PE (private-equity) ownership of the chains, franchising, or venture bets on direct-to-consumer (DTC) brands.

---

2. What it is, and how it's structured

Scope (NAICS 456191 "Food (Health) Supplement Retailers"): establishments primarily engaged in retailing food-supplement products, vitamins, minerals, herbs, nutrition supplements, sports/body-enhancing supplements, protein, probiotics, and gummies.[1] The unifying trait is a store (or store-branded website) whose primary business is supplements. Under the 2017 NAICS this activity sat in code 446191; the 2022 revision renumbered it to 456191, which is the code used here.[2]

What it excludes, important, because most supplement dollars are spent outside this code:

• Pharmacies and drug retailers (NAICS 456110), CVS, Walgreens, and other drugstores that sell supplements alongside prescriptions.[1]
• Cosmetics/beauty retailers (456120) and optical-goods retailers (456130), adjacent health-and-personal-care specialty codes.[1]
• Food and beverage retailers (NAICS subsector 445), supermarkets and natural-grocery chains (e.g., Natural Grocers, Sprouts) whose primary business is groceries even when they carry deep supplement sets.[1]
• General-merchandise / warehouse clubs and supercenters (NAICS subsector 455), Walmart, Target, Costco.
• Electronic shopping / mail-order (NAICS 4541), pure online sellers such as Amazon, iHerb, and Vitacost sit here, not in 456191.
• Direct sellers / multi-level marketers (MLMs), Herbalife, USANA, Nature's Sunshine and similar network-marketing supplement companies are classified as direct-selling, not store retail. Large supplement brands are typically classified as manufacturers or wholesalers.

Ownership mix. The industry is a barbell: two national chains (GNC, The Vitamin Shoppe) plus a very long tail of small independents and franchisees. GNC alone runs roughly 2,300 U.S. locations, of which about 800 are independently owned franchises rather than corporate stores.[23] That franchise structure means many "establishments" in the federal count are small, individually owned businesses. Federal concentration data confirm the fragmentation (Section 3).

---

3. How big it is

Our ground-truth federal figures for NAICS 456191:

Read on concentration: an HHI (a standard 0–10,000 market-concentration score) of 167 is very low, anything under 1,500 is considered "unconcentrated" by U.S. antitrust agencies. With the top four firms at just 21.5% of sales and 8,000-plus firms in total, this is a fragmented industry with a large small-operator/franchise tail, not a two-company oligopoly. The SBA (Small Business Administration) $22.5M figure is a program-eligibility threshold, not an estimate of typical retailer size.

The undercount caveat, this code captures only one channel, one way. Two limits apply. First, CBP counts only businesses with paid employees, so nonemployer, solo, and home-based operators (and some online sellers) are missing or classified elsewhere, a real gap in a tiny-operator-heavy trade. Second, and larger: the $21.6 billion of specialty-store receipts is a fraction of what Americans spend on supplements. Total U.S. dietary-supplement sales are estimated at roughly $60–73 billion; one 2024 industry tally (Nutrition Business Journal, via Nutraceuticals World) put it near $72.9 billion.[7] The difference sits in the excluded channels above: mass merchants, warehouse clubs, drugstores, grocery, online marketplaces, and direct sellers. Specialty stores are still the single largest store-type channel in North America (about 46% of the category by one estimate),[8] but online is the fastest-growing. So NAICS 456191 is best read as the specialty brick-and-mortar slice of a much larger supplement economy, roughly a quarter to a third of total supplement retail spend, not the whole industry. (A broader private tally, First Research, counts ~11,000 establishments and ~$21 billion using a wider definition;[9] our federal figures are narrower and preferred here.)

The federal file carries no industry-wide same-store sales, online-sales share, gross margin, inventory-turn, or retention data, those cannot be inferred from the receipts total and are not asserted here.

---

4. The investable universe

There is no pure-play, U.S.-listed supplement retailer to buy. Both national chains are private, and the biggest online players are private or divisions of larger companies. Public-market exposure is indirect. The cleanest way to organize the universe is by how directly each name touches supplement retail. (Company figures below are from the most recent SEC, Securities and Exchange Commission, filings; supplement revenue is rarely broken out.)

A. Diversified / specialty retailers with real supplement-retail exposure (public)

B. Supplement brand and nutrition makers (public), they make what these stores sell

C. The direct specialty-retail layer is private / other-owned

The federal statistics do not provide a complete ownership census of private chains, franchisees, brands, or nonemployer businesses.

---

5. How the money works

Supplement retail is a high-gross-margin, small-box, repeat-purchase business: the retailer buys finished product from brands, distributors, or contract manufacturers and earns the spread between selling price and product cost. The levers that matter:

• Gross margin and private label. Supplements carry high gross margins; branded product is lower-margin and its price is easy to compare online, so the chains push their own private-label lines (GNC-branded, Vitamin Shoppe-branded), which can carry substantially higher margins and build loyalty. Mix-shift toward private label is the single biggest margin lever, but it also concentrates product-liability and quality-control risk on the retailer.[29]
• Comparable-store (same-store) sales, the core retail health metric: how much a store open at least a year grows year-over-year. Positive comps signal the format still works; multi-year weakness in mall-based comps is exactly why both chains restructured. Natural Grocers and Sprouts both flag comparable sales, transaction counts, average ticket, inventory/shrink, and occupancy as key operating measures.[12][13]
• Unit economics. A typical store is a small (~1,500–2,000 sq ft) strip-mall or mall unit. Fixed occupancy costs create operating leverage when sales rise and cost deleverage when traffic falls; profit hinges on foot traffic, average basket size, and rent as a share of sales, GNC's historical over-exposure to expensive mall leases was a key reason it faltered.
• Franchising = capital-light revenue. GNC franchises ~800 U.S. units, earning franchise royalties plus wholesale product sales to franchisees, with the franchisee carrying rent and labor. A GNC franchise has reported median gross revenue around $444,000 per unit.[24] For the franchisor this is a higher-return, lower-capital model than owning stores.
• Loyalty and subscription/auto-ship. Recurring "subscribe-and-save" auto-ship converts a discretionary purchase into predictable, higher-retention revenue and is central to the online model.
• Wholesale/mass distribution and inventory. Chains and brands also sell into Walmart/Amazon (high volume, low margin, reach). Thousands of SKUs, expiration dating, and shrink management drive working capital and markdowns.

Direct-selling economics differ and are not directly comparable to store retail: those companies source or make product, then pay commissions to independent distributors, their reported sales and margins reflect a different model.

---

6. What drives demand

• Broad, habitual usage. ~75% of U.S. adults use supplements, a rate that has held at high levels; users skew brand-loyal and prefer supplements to over-the-counter or prescription drugs where possible.[6]
• Aging + preventive-health culture. Older consumers buy more; the wider "wellness"/self-care movement expands the buyer base and basket.
• Specialty-ingredient cycles. Categories rise and fall fast: magnesium usage jumped to 23% of users (2024) from 19% (2023), melatonin to 16% (from 10% in 2020), and ashwagandha to 8% (from 2% in 2020); personalization is a stated priority for ~69% of buyers.[6]
• Sports nutrition and protein. Protein and creatine are durable growth engines; creatine dollar sales grew sharply (up ~72% in the multi-outlet channel by one read). BellRing cites protein awareness, snacking, and on-the-go consumption as category drivers.[10][18]
• The GLP-1 weight-loss wave. GLP-1 (glucagon-like peptide-1) drugs, the Ozempic/Wegovy class, are a two-sided force. Users lose muscle as well as fat, driving demand for protein, creatine, and "GLP-1 companion" supplements, a GLP-1 nutritional-support niche projected to grow from ~$4.1B (2025) to ~$13B (2035).[11] But appetite suppression can dent some snack-adjacent and legacy weight-loss categories.
• Digital discovery. Social-commerce and influencers now drive much of what sells, accelerating category fads and shifting share online.
• Discretionary-spending sensitivity. Basic vitamins are relatively resilient (a "self-care" staple); premium sports-nutrition, beauty, weight-management, and novelty products are more discretionary, and consumers trade down to private label or cheaper channels when budgets tighten.

---

7. Regulation

Supplements sit in a distinctive, relatively light regulatory regime, a core part of the investment thesis and its main risk.

• DSHEA (Dietary Supplement Health and Education Act, 1994). The foundational law, which amended the Federal Food, Drug, and Cosmetic Act. Supplements are regulated as food, not drugs: the FDA (Food and Drug Administration) does not pre-approve them for safety, effectiveness, or labeling; the company is responsible for safety and compliance before sale, with the FDA handling post-market oversight.[32][34]
• Structure/function claims. Labels may say a product "supports immune health" but cannot claim to diagnose, treat, cure, or prevent disease (that's drug territory). Such claims must carry the FDA-not-evaluated disclaimer and be notified to FDA.[33]
• New Dietary Ingredient (NDI) notifications must be filed with FDA at least ~75 days before marketing a genuinely new ingredient, and manufacturing must follow current Good Manufacturing Practices (cGMP, 21 CFR Part 111).[34][35]
• Advertising is policed by the FTC (Federal Trade Commission), which requires health claims to be truthful and backed by competent, reliable scientific evidence, a standard that reaches websites, influencers, testimonials, and distributor claims.[38]
• State layer. California's Prop 65 warnings apply; several states (New York, California) have moved to restrict sales of certain weight-loss/diet supplements to minors, a retailer compliance burden.
• The 2025–26 wildcard: MAHA / RFK Jr. Under the "Make America Healthy Again" agenda, with Robert F. Kennedy Jr. as HHS (Health and Human Services) Secretary, the administration is broadly supplement-friendly but is also pushing DSHEA "modernization", including talk of a mandatory product listing (MPL) requirement, tighter ingredient oversight, and reform of the self-affirmed GRAS ("generally recognized as safe") pathway.[39] In a December 2025 industry letter, FDA said it was considering changes to DSHEA disclaimer placement and would exercise enforcement discretion meanwhile, a policy-development risk, not yet a final rule.[36][37] For retailers this cuts both ways: a higher-trust, better-regulated category could support pricing and premium brands, while new listing/testing costs and possible ingredient restrictions raise compliance overhead.
• Ownership scrutiny. GNC's Chinese state-linked ownership has drawn political attention, including 2025 legislation proposed to bar GNC from U.S. military bases.[22]

---

8. Competitive dynamics & consolidation

• Fragmented and channel-pressured. Federal data show low concentration (CR4 21.5%, HHI 167).[4] The competitive threat isn't a dominant rival within the code, it's the channels outside it: Amazon and iHerb online, Costco and Walmart on price, drugstores and grocers on convenience, and DTC brands going straight to the consumer. Entry is cheap for a basic online assortment, but scale matters in sourcing, fulfillment, quality systems, data, and private label. The highest-volume supplement sales now run through supermarkets/superstores and online, not specialty stores.[9]
• A decade of structural decline for the specialty box. Both national chains passed through distress: GNC filed Chapter 11 in 2020 (owing ~$895M) and emerged under Harbin ownership;[22] The Vitamin Shoppe ended up inside Franchise Group, which itself filed Chapter 11 in late 2024 (~$2B debt) and sold the chain to PE in 2025.[25][27] The lesson: too many high-rent mall leases against a commoditized, price-transparent product.
• Consolidation is happening at the edges, not the center. Online is consolidating, iHerb bought Vitacost from Kroger (2026), combining two of the largest online supplement retailers.[28] PE is re-tooling the brick-and-mortar chains (Kingswood/PIP at Vitamin Shoppe). Brand-side M&A is active: Nestlé completed a $5.75B acquisition of core Bountiful Company brands in 2021 (Nature's Bounty, Solgar, Osteo Bi-Flex, Puritan's Pride, Ester-C, Sundown), and deals continue in sports nutrition and DTC.[31] Concentration is thus more visible in branded product and chain ownership than in national retail market share.
• How survivors compete. Private-label margin, expert in-store service and curation, loyalty/auto-ship, omnichannel (buy-online/pick-up-in-store), and franchising for asset-light expansion. Sponsor-backed owners can fund those upgrades, but leverage magnifies execution and refinancing risk.

---

9. Risks

• Channel disintermediation. The structural risk. Amazon, iHerb, Costco, Walmart, and DTC brands can undercut specialty stores on price and convenience; the format's share has been eroding for years.
• Product safety, adulteration, and liability. Supplements periodically face contamination, spiked "sports/sexual-enhancement" products, mislabeling, and recall/reputational events, and the retailer can be exposed even when manufacturing is outsourced.
• Regulatory tightening. DSHEA modernization, a mandatory product listing, GRAS reform, ingredient bans, or aggressive claims enforcement would raise costs and could pull popular SKUs.[36][39]
• Supply chain and input costs. Heavy reliance on imported raw materials (much vitamin/ingredient production is concentrated in China) exposes margins to tariffs, freight, and geopolitical disruption; cyber and logistics failures add tail risk.
• Fad/category concentration and inventory. Fast-cycling ingredients mean today's growth engine (ashwagandha, GLP-1 companions) can fade; misjudging inventory leads to markdowns and dated-product write-offs.
• Discretionary spending. Semi-discretionary demand softens and trades down in a downturn.
• Real estate. Brick-and-mortar operators carry lease exposure; the mall-format legacy remains a drag.
• GLP-1 is double-edged. A tailwind for protein/muscle-preservation but a potential headwind for appetite-driven and legacy weight-loss categories.
• Direct-selling risk (for the MLM proxies). Distributor conduct, earnings claims, and compensation-plan design create added FTC and state-regulatory exposure.[38]
• Private-company opacity and political risk. GNC and The Vitamin Shoppe disclose far less than listed firms, so buyers must diligence debt, leases, store-level profitability, inventory, and covenants; foreign-state ownership of GNC also invites recurring policy scrutiny.[22]

---

10. How to invest, and the outlook

Public-market routes (all indirect, no pure-play retailer exists), in four buckets:

1. Specialty-retail proxies: Natural Grocers (NGVC) is the closest listed proxy for supplement-heavy specialty retail; Sprouts (SFM) is a lighter version, adjust for their grocery mix.[12][13]
2. Direct selling / DTC: Herbalife (HLF), USANA (USNA), Nature's Sunshine (NATR), LifeVantage (LFVN), Medifast (MED), the most concentrated supplement-demand exposure on public markets, but with direct-selling regulatory risk.
3. Brands / upstream nutrition: BellRing (BRBR), Simply Good Foods (SMPL), Glanbia (GLB), own the product, not the store.
4. Distribution channels that win the volume shift: Amazon (AMZN), Costco (COST), Walmart (WMT), supplements are a small slice of each.

Compare names using comparable-store sales, transaction growth, average ticket, gross margin, inventory turns, private-label share, digital repeat rates, rent, leverage, and free cash flow. For valuation, apply price-to-sales or EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, and amortization) only after adjusting for geographic mix, direct-selling exposure, and the share of revenue actually tied to supplements.

Private-market routes (the direct exposure):

• Private equity is the way to own the specialty-retail layer, The Vitamin Shoppe (Kingswood/PIP) and GNC (Harbin) sit here, alongside PE-backed iHerb; also upstream in private-label manufacturing (e.g., IVC).[25][28]
• Franchising, operating a GNC franchise is a direct small-business route (median unit revenue ~$444K).[24]
• Venture/angel, the most active growth area is DTC and personalized/subscription supplement brands.

Private buyers should underwrite store-level cash flow, lease obligations, product-quality and regulatory files, supplier concentration, aged inventory, customer-acquisition cost, repeat-purchase rates, private-label economics, and debt service.

Outlook (forward-looking judgment). Underlying U.S. supplement demand looks structurally healthy, high, sticky usage; aging demographics; and the GLP-1 protein tailwind point to continued modest, mid-to-high-single-digit category growth.[7][11] But the specialty-store channel this NAICS code measures is likely to keep ceding share to online and mass channels; value should accrue to omnichannel operators with strong private label, loyalty/auto-ship, and franchise leverage rather than to legacy mall boxes. Near-term catalysts to watch: (1) the shape of MAHA/DSHEA regulatory reform, which could reset the category's trust and cost structure; (2) further online consolidation and pricing after the iHerb–Vitacost tie-up (and any eventual iHerb IPO); and (3) how durably the GLP-1 wave converts into protein, creatine, and muscle-preservation sales. The federal data contain no official forecast, so no specific growth rate is asserted. For most public investors the practical exposure is a brand maker or a diversified retailer; direct ownership of a supplement store remains a private-market or franchising decision.

---

Sources

1. U.S. Census Bureau, "2022 NAICS — 456191 Food (Health) Supplement Retailers (definition and exclusions)." https://www.census.gov/naics/?details=456191&year=2022
2. U.S. Bureau of Labor Statistics, "2022 NAICS Revision and Crosswalk" (446191 → 456191). https://www.bls.gov/ces/naics/naics-2022.htm
3. U.S. Census Bureau, County Business Patterns (CBP), NAICS 456191, 2023 (establishments, employment, annual and first-quarter payroll). https://www.census.gov/programs-surveys/cbp.html
4. U.S. Census Bureau, 2022 Economic Census — Concentration of Sales by Largest Firms, NAICS 456191 (firms, receipts, CR4/CR8/CR20/CR50, HHI). https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
5. U.S. Small Business Administration, "Table of Size Standards," NAICS 456191, 2023. https://www.sba.gov/document/support-table-size-standards
6. Council for Responsible Nutrition / Ipsos, "2024 CRN Consumer Survey: 75% of Americans use supplements," 2024. https://www.nutraingredients.com/Article/2024/11/07/2024-CRN-Consumer-Survey-75-of-Americans-use-supplements/
7. Nutraceuticals World, "U.S. Supplement Sales Hit $72.88 Billion…," 2024 (Nutrition Business Journal data). https://www.nutraceuticalsworld.com/exclusives/u-s-supplement-sales-hit-72-88-billion-as-sports-nutrition-and-digital-discovery-drive-growth/
8. Mordor Intelligence / Grand View Research, "North America Dietary Supplement Market — specialty stores ~46% channel share," 2024. https://www.mordorintelligence.com/industry-reports/north-america-dietary-supplement-market
9. First Research, "Health Supplement Stores — Industry Profile" (~11,000 establishments; ~$21B; channel competition), 2024. https://www.firstresearch.com/Industry-Research/Health-Supplement-Stores.html
10. Nutritional Outlook, "Why creatine and protein continue to see significant sales growth," 2025. https://www.nutritionaloutlook.com/view/why-creatine-and-protein-continue-to-see-significant-sales-growth-in-the-nutraceutical-space
11. Future Market Insights, "GLP-1 Nutritional Support Market Size & Share 2025–2035," 2025. https://www.futuremarketinsights.com/reports/glp-1-nutritional-support-market
12. U.S. SEC, Natural Grocers by Vitamin Cottage 2025 Form 10-K (net sales ~$1.33B, net income ~$46.4M, 168 stores/21 states, comps +7.3%, gross margin 29.9%). https://www.sec.gov/Archives/edgar/data/1547459/000143774925037556/ngvc20250930_10k.htm
13. U.S. SEC, Sprouts Farmers Market 2025 Form 10-K (gross margin ~38.8%; operating measures). https://www.sec.gov/Archives/edgar/data/1575515/000157551526000008/sfm-20251228.htm
14. U.S. SEC, USANA Health Sciences 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm
15. U.S. SEC, Nature's Sunshine Products 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/275053/000162828026016540/natr-20251231.htm
16. Herbalife, 2025 Annual Report / Form 10-K. https://ir.herbalife.com/sec-filings
17. U.S. SEC, LifeVantage 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/849146/000084914625000068/lfvn-20250630.htm
18. U.S. SEC, BellRing Brands 2025 Form 10-K (protein, snacking, GLP-1 category trends). https://www.sec.gov/Archives/edgar/data/1772016/000177201625000153/brbr-20250930.htm
19. U.S. SEC, selected 2025–2026 annual reports: Walmart, Costco, Amazon, CVS Health (channel exposure; supplement revenue not separately disclosed). https://www.sec.gov/cgi-bin/browse-edgar
20. McCarthy Tétrault, "Harbin Pharmaceutical's ~US$760–770M agreement to acquire GNC approved by bankruptcy court," 2020. https://www.mccarthy.ca/en/experience/harbin-pharmaceutical-s-us-760m-agreement-to-acquire-gnc-approved-by-bankruptcy-court
21. U.S. SEC, GNC Holdings Form 8-K — completion of acquisition by Harbin (via ZT Biopharmaceutical LLC), 2020. https://www.sec.gov/Archives/edgar/data/1502034/000119312520265653/d25873d8k.htm
22. Wikipedia, "GNC (company)" (Chapter 11, ~$895M debt, Harbin ownership, military-base bill), 2025. https://en.wikipedia.org/wiki/GNC_(company)
23. Sharpsheets, "GNC Franchise FDD, Profits & Costs (2025)" (~2,300 U.S. locations, ~800 franchised). https://sharpsheets.io/blog/gnc-franchise-costs-profits/
24. FranchiseVS, "GNC" franchise profile (median unit revenue ~$444K), 2025. https://franchisevs.com/franchise/gnc/
25. Retail Dive, "The Vitamin Shoppe to be sold to private equity for nearly $195M" (~$193.5M; Kingswood/PIP), 2025. https://www.retaildive.com/news/the-vitamin-shoppe-private-equity-kingswood-capital-acquisition/745742/
26. Kingswood Capital Management / The Vitamin Shoppe, "…Complete Acquisition of The Vitamin Shoppe" (~635 stores; ~700 brand partners), May 2025. https://press.vitaminshoppe.com/2025-05-20-Kingswood-Capital-Management-and-Performance-Investment-Partners-Complete-Acquisition-of-The-Vitamin-Shoppe-R/
27. Retail Dive, "Vitamin Shoppe owner files for bankruptcy" (Franchise Group Chapter 11, ~$2B debt), 2024. https://www.retaildive.com/news/vitamin-shoppe-owner-files-bankruptcy-franchise-group/731857/
28. iHerb, "iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger" (>$2.4B 2024 net sales; completed Jan 2026). https://www.iherb.com/pressreleases/iherb-acquires-vitacost-business/2280
29. Retail Dive, "GNC turns to private labels for growth amid turnaround," 2018. https://www.retaildive.com/news/gnc-turns-to-private-labels-for-growth-amid-turnaround/528771/
30. International Vitamin Corporation, "Private Label Supplement Manufacturing," 2026. https://ivcinc.com/private-label-program/
31. Nestlé, "Nestlé to acquire core brands of The Bountiful Company" ($5.75B), 2021. https://www.nestle.com/media/pressreleases/allpressreleases/nestle-acquire-core-brands-the-bountiful-company-health-nutrition-portfolio
32. Council for Responsible Nutrition, "Dietary Supplement Health & Education Act (DSHEA)," 1994. https://www.crnusa.org/regulation-legislation/fda-ftc-regulations/dietary-supplement-health-education-act-dshea
33. U.S. Food and Drug Administration, "Structure/Function Claims," 2024. https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims
34. U.S. Food and Drug Administration, "Questions and Answers on Dietary Supplements" (no pre-approval; NDI 75-day notification). https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
35. U.S. Food and Drug Administration, "Small Entity Compliance Guide: cGMP for Dietary Supplements (21 CFR Part 111)." https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling
36. U.S. Food and Drug Administration, "Letter to the Dietary Supplement Industry on the DSHEA Disclaimer," Dec 2025. https://www.fda.gov/food/information-industry-dietary-supplements/letter-dietary-supplement-industry-dshea-disclaimer
37. Consumer Healthcare Products Association, "CHPA Urges Continued Modernization as FDA Signals Update to DSHEA Labeling Requirements," 2025. https://www.chpa.org/news/2025/12/chpa-urges-continued-modernization-fda-signals-update-dshea-labeling-requirements
38. Federal Trade Commission, "Health Products Compliance Guidance," 2022. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
39. SupplySide SJ, "RFK Jr.'s HHS showing mixed signals for dietary supplement sector" (MPL, GRAS reform), 2025. https://www.supplysidesj.com/supplement-regulations/rfk-jr-s-hhs-showing-mixed-signals-for-dietary-supplement-sector